Compound ID | 447

Update compound information

LB10517

Synonym(s): LK10517

Class: Beta-lactam

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive & Gram-negative
Mechanism of action: Cell wall synthesis inhibitor
Description: Injectable cephalosporin; Kwak JH, Oh JI, Song HK, et al. In vitro and in vivo activities of LK 10517, a novel catechol-substituted Cephalosporin. 34th-Intersci-Conf-Antimicrobial-Agents-Chemother 1994; 160.
Institute where first reported: Lucky Biotech Institute, US (LG Chem Investment, South Korea)
Year first mentioned: 1994
Highest development stage: Phase 2
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 705.66
Iso. SMILES: C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=N/O[C@@H](C3=CC(=C(C=C3)O)O)C(=O)O)/C4=CSC(=N4)N)C(=O)[O-])/C=C/CN5C=NC(=CC5=N)N.[Na+]
InChI Key: UYHYRBVGPCDVGT-AIVDZQKASA-M
Can. SMILES: C(=C\C1=C(C(=O)[O-])N2C(=O)[C@H]([C@H]2SC1)NC(=O)/C(=N/O[C@@H](C3=CC=C(C(=C3)O)O)C(=O)O)/C4=CSC(=N4)N)/CN5C=NC(=CC5=N)N.[Na+]
InChI: InChI=1S/C27H25N9O9S2.Na/c28-16-7-17(29)35(10-31-16)5-1-2-12-8-46-24-19(23(40)36(24)20(12)25(41)42)33-22(39)18(13-9-47-27(30)32-13)34-45-21(26(43)44)11-3-4-14(37)15(38)6-11;/h1-4,6-7,9-10,19,21,24,29,37-38H,5,8,28H2,(H2,30,32)(H,33,39)(H,41,42)(H,43,44);/q;+1/p-1/b2-1+,29-17?,34-18+;/t19-,21+,24-;/m1./s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/23670895
Citations:
  • https://link.springer.com/article/10.1007/BF02976819
  • https://doi.org/10.1093/jac/37.4.711

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.